BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

780 related articles for article (PubMed ID: 30080677)

  • 21. DNA vaccination elicits protective immune responses against pandemic and classic swine influenza viruses in pigs.
    Gorres JP; Lager KM; Kong WP; Royals M; Todd JP; Vincent AL; Wei CJ; Loving CL; Zanella EL; Janke B; Kehrli ME; Nabel GJ; Rao SS
    Clin Vaccine Immunol; 2011 Nov; 18(11):1987-95. PubMed ID: 21918118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and identification of Eurasian avian-like H1N1 swine influenza virus and evaluation of their pathogenicity and immune protective effects in pigs.
    Yang Y; Huang Y; Huang K; Zhang Y; Hu X; Zou W; Wu C; Hui X; Li C; Zhao Y; Sun X; Zou Z; Jin M
    Vet Microbiol; 2023 Sep; 284():109827. PubMed ID: 37542928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine.
    Vincent AL; Lager KM; Janke BH; Gramer MR; Richt JA
    Vet Microbiol; 2008 Jan; 126(4):310-23. PubMed ID: 17719188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.
    Jadhao SJ; Achenbach J; Swayne DE; Donis R; Cox N; Matsuoka Y
    Vaccine; 2008 Mar; 26(14):1742-50. PubMed ID: 18336962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses.
    Pena L; Vincent AL; Ye J; Ciacci-Zanella JR; Angel M; Lorusso A; Gauger PC; Janke BH; Loving CL; Perez DR
    J Virol; 2011 Jan; 85(1):456-69. PubMed ID: 20962084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modified vaccinia virus Ankara expressing the hemagglutinin of pandemic (H1N1) 2009 virus induces cross-protective immunity against Eurasian 'avian-like' H1N1 swine viruses in mice.
    Castrucci MR; Facchini M; Di Mario G; Garulli B; Sciaraffia E; Meola M; Fabiani C; De Marco MA; Cordioli P; Siccardi A; Kawaoka Y; Donatelli I
    Influenza Other Respir Viruses; 2014 May; 8(3):367-75. PubMed ID: 24373385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune efficacy of an adenoviral vector-based swine influenza vaccine against antigenically distinct H1N1 strains in mice.
    Wu Y; Yang D; Xu B; Liang W; Sui J; Chen Y; Yang H; Chen H; Wei P; Qiao C
    Antiviral Res; 2017 Nov; 147():29-36. PubMed ID: 28941982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs.
    Masic A; Lu X; Li J; Mutwiri GK; Babiuk LA; Brown EG; Zhou Y
    Vaccine; 2010 Oct; 28(43):7098-108. PubMed ID: 20708697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalent Eurasian avian-like H1N1 swine influenza virus with 2009 pandemic viral genes facilitating human infection.
    Sun H; Xiao Y; Liu J; Wang D; Li F; Wang C; Li C; Zhu J; Song J; Sun H; Jiang Z; Liu L; Zhang X; Wei K; Hou D; Pu J; Sun Y; Tong Q; Bi Y; Chang KC; Liu S; Gao GF; Liu J
    Proc Natl Acad Sci U S A; 2020 Jul; 117(29):17204-17210. PubMed ID: 32601207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.
    Kitikoon P; Nilubol D; Erickson BJ; Janke BH; Hoover TC; Sornsen SA; Thacker EL
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):117-28. PubMed ID: 16621020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A two dose immunization with an inactivated reassortant H5N2 virus protects chickens against lethal challenge with homologous 2.3.2.1 clade and heterologous 2.2 clade highly pathogenic avian influenza H5N1 viruses.
    Bhat S; Sood R; Shukla S; Khandia R; Pateriya AK; Kumar N; Singh VK; Kalaiyarasu S; Kumar M; Bhatia S
    Vet Microbiol; 2018 Apr; 217():149-157. PubMed ID: 29615248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal Antibody Against HA Protein of the European Avian-Like H1N1 Swine Influenza Virus.
    Wang Q; Wang SY; Zhang P; Liu XM; Yu LX; Shan TL; Tong W; Zhou YJ; Li GX; Zheng H; Gao F; Jiang YF; Kong N; Li LW; Tong GZ; Yu H
    Monoclon Antib Immunodiagn Immunother; 2018 Apr; 37(2):69-72. PubMed ID: 29630477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization of a novel reassortant H1N2 influenza virus containing genes from the 2009 pandemic human H1N1 virus in swine from eastern China.
    Peng X; Wu H; Xu L; Peng X; Cheng L; Jin C; Xie T; Lu X; Wu N
    Virus Genes; 2016 Jun; 52(3):405-10. PubMed ID: 26980674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A polyvalent influenza A DNA vaccine induces heterologous immunity and protects pigs against pandemic A(H1N1)pdm09 virus infection.
    Bragstad K; Vinner L; Hansen MS; Nielsen J; Fomsgaard A
    Vaccine; 2013 Apr; 31(18):2281-8. PubMed ID: 23499598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polyanhydride nanovaccine against swine influenza virus in pigs.
    Dhakal S; Goodman J; Bondra K; Lakshmanappa YS; Hiremath J; Shyu DL; Ouyang K; Kang KI; Krakowka S; Wannemuehler MJ; Won Lee C; Narasimhan B; Renukaradhya GJ
    Vaccine; 2017 Feb; 35(8):1124-1131. PubMed ID: 28117173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A bivalent live attenuated influenza virus vaccine protects against H1N2 and H3N2 viral infection in swine.
    Landreth S; Detmer S; Gerdts V; Zhou Y
    Vet Microbiol; 2021 Feb; 253():108968. PubMed ID: 33418392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants.
    Klingbeil K; Lange E; Blohm U; Teifke JP; Mettenleiter TC; Fuchs W
    Virus Res; 2015 Mar; 199():20-30. PubMed ID: 25599604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of commercial swine influenza vaccines against challenge with a recent European H1N1 field isolate.
    Kyriakis CS; Gramer MR; Barbé F; Van Doorsselaere J; Van Reeth K
    Vet Microbiol; 2010 Jul; 144(1-2):67-74. PubMed ID: 20116942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel reassortant influenza A (H1N1) virus infection in swine in Shandong Province, eastern China.
    Yu Z; Cheng K; He H; Wu J
    Transbound Emerg Dis; 2020 Jan; 67(1):450-454. PubMed ID: 31535780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA vaccine based on conserved HA-peptides induces strong immune response and rapidly clears influenza virus infection from vaccinated pigs.
    Sisteré-Oró M; López-Serrano S; Veljkovic V; Pina-Pedrero S; Vergara-Alert J; Córdoba L; Pérez-Maillo M; Pleguezuelos P; Vidal E; Segalés J; Nielsen J; Fomsgaard A; Darji A
    PLoS One; 2019; 14(9):e0222201. PubMed ID: 31553755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.